SBI Biotech Co., Ltd.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 2001-03-30
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbibiotech.jp
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
- First Posted Date
- 2009-12-18
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- SBI Biotech Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT01035216
- Locations
- 🇺🇸
Univ. of San Diego: Moores UCSD Cancer Center, La Jolla, California, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸North Shore University Hospital, New Hyde Park, New York, United States
News
No news found